Bioprosthetics Market - Global Professional Analysis and Forecast to 2026

Oct 10, 2019  |  172 PAGES  |  REPORT CODE: CMM204022
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Bioprosthetics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 13.8% during the forecast period.

This report presents the market size and development trends by detailing the Bioprosthetics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Bioprosthetics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Bioprosthetics industry and will help you to build a panoramic view of the industrial development.

Bioprosthetics Market, By Type:

  • Allograft

  • Xenograft

  • Porcine

  • Bovine

Bioprosthetics Market, By Application:

  • Cardiovascular

  • Plastic Surgery & Wound Healing

  • Others

Some of the leading players are as follows:

  • Labcor Laboratorios Ltd.

  • LeMaitre Vascular, Inc.

  • Edwards Lifesciences Corporation

  • Sorin Group

  • CryoLife, Inc.

  • Maquet Metinge Group

  • St. Jude Medical, Inc.

  • JenaValve Technology GmbH

  • Organogenesis, Inc.

  • Medtronic Plc.

  • Braile Biomedica, Inc.

  • LifeCell International

  • Humacyte, Inc.

  • Aortech International Plc

  • Ethicon, Inc.

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Bioprosthetics Market: Technology Type Analysis

  • 4.1 Bioprosthetics Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Bioprosthetics Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Allograft

    • 4.3.2 Xenograft

    • 4.3.3 Porcine

    • 4.3.4 Bovine

5 Bioprosthetics Market: Product Analysis

  • 5.1 Bioprosthetics Product Market Share Analysis, 2018 & 2026

  • 5.2 Bioprosthetics Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Bioprosthetics Market: Application Analysis

  • 6.1 Bioprosthetics Application Market Share Analysis, 2018 & 2026

  • 6.2 Bioprosthetics Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Cardiovascular

    • 6.3.2 Plastic Surgery & Wound Healing

    • 6.3.3 Others

7 Bioprosthetics Market: Regional Analysis

  • 7.1 Bioprosthetics Regional Market Share Analysis, 2018 & 2026

  • 7.2 Bioprosthetics Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Labcor Laboratorios Ltd.

    • 9.1.1 Labcor Laboratorios Ltd. Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 LeMaitre Vascular, Inc.

    • 9.2.1 LeMaitre Vascular, Inc. Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Edwards Lifesciences Corporation

    • 9.3.1 Edwards Lifesciences Corporation Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Sorin Group

    • 9.4.1 Sorin Group Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 CryoLife, Inc.

    • 9.5.1 CryoLife, Inc. Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Maquet Metinge Group

    • 9.6.1 Maquet Metinge Group Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 St. Jude Medical, Inc.

    • 9.7.1 St. Jude Medical, Inc. Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 JenaValve Technology GmbH

    • 9.8.1 JenaValve Technology GmbH Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Organogenesis, Inc.

    • 9.9.1 Organogenesis, Inc. Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Medtronic Plc.

    • 9.10.1 Medtronic Plc. Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Braile Biomedica, Inc.

    • 9.11.1 Braile Biomedica, Inc. Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 LifeCell International

    • 9.12.1 LifeCell International Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Humacyte, Inc.

    • 9.13.1 Humacyte, Inc. Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Aortech International Plc

    • 9.14.1 Aortech International Plc Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Ethicon, Inc.

    • 9.15.1 Ethicon, Inc. Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

 

The List of Tables and Figures (Totals 97 Figures and 141 Tables)

  • Figure Allograft Bioprosthetics market, 2015 - 2026 (USD Million)

  • Figure Xenograft Bioprosthetics market, 2015 - 2026 (USD Million)

  • Figure Porcine Bioprosthetics market, 2015 - 2026 (USD Million)

  • Figure Bovine Bioprosthetics market, 2015 - 2026 (USD Million)

  • Figure Cardiovascular market, 2015 - 2026 (USD Million)

  • Figure Plastic Surgery & Wound Healing market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Bioprosthetics market, by country, 2015 - 2026 (USD Million)

  • Table North America Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table North America Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table North America Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table Canada Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table Canada Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Europe Bioprosthetics market, by country, 2015 - 2026 (USD Million)

  • Table Europe Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table Europe Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table Europe Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table Germany Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table Germany Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table France Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table France Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table Italy Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table Italy Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table Spain Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table Spain Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Bioprosthetics market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table China Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table China Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table Japan Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table Japan Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table India Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table India Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Bioprosthetics market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table MEA Bioprosthetics market, by country, 2015 - 2026 (USD Million)

  • Table MEA Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table MEA Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table MEA Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Bioprosthetics market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Bioprosthetics market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Bioprosthetics market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Labcor Laboratorios Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table LeMaitre Vascular, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Edwards Lifesciences Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sorin Group Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CryoLife, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Maquet Metinge Group Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table St. Jude Medical, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table JenaValve Technology GmbH Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Organogenesis, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Medtronic Plc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Braile Biomedica, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table LifeCell International Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Humacyte, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Aortech International Plc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ethicon, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top